Teva Photo: Reuters

Teva seeks FDA marketing nod for potential blockbuster drug

Citigroup estimates that sales of migraine treatment Fremanezumab, which might be launched next year, could reach $2 billion annually.

OPINION & FEATURES
Yaron Daniely Photo: Yonatan Bloom Yissum CEO seeks to connect academia and industry

Dr. Yaron Daniely reveals that Yissum gave Hebrew University over NIS 800 million in research funds, royalties, and shares over the past decade.

Joseph Weiss Photo: Kfir Ziv IAI CEO navigates between corruption and aerospace

Joseph Weiss tells "Globes" about the challenges he faces including missile defense, exploding rocket launchers and the refusal of the US to grant him a visa.

Elsight system  photo: company website Australia discovers Elsight

The Israeli data transmission and security company has seen its share price quadruple within weeks on the Australian Stock Exchange.

Navot Volk Photo: Mor Shmoshkovitz Israeli startups beginning to see benefits of New York

Some Israeli startups prefer to set up their headquarters in New York rather than Silicon Valley. Microsoft Accelerator Israel head Navot Volk explains why.

Amiram Barkat Israel's budget surpluses are becoming a habit

Will 2017's NIS 10 billion budget surplus - the fifth consecutive such annual surplus - be used for cutting government debt or buying voters with tax cuts? 

Eli Tsipori Teva a victim of Copaxone's success

Teva's reliance on Copaxone made the company complacent, obese, and excessively self-confident.

Shlomit Weiss Photo: Yonatan Bloom Israel's "silicon woman" joins Mellanox

Shlomit Weiss reflects on 28 years of achievement at Intel and the challenges facing her as senior VP silicon engineering at Mellanox.

Nir Shalom  photo: Eyal Izhar "When AT&T faces complex challenges, it turns to us"

Nir Shalom, who runs AT&T's Israel development center, explains what it offers the US telecoms giant.

King Abdullah II photo: Reuters Downfall of a Jordanian option

A heartening tale of how journalistic solidarity trumped a political illusion.

Assaf Touboul and Ronen Sheashua Photo: Eyal Yitzhar 5G mobile revolution designed in Israel

Qualcomm Israel's Assaf Touboul and Ronen Sheashua tell "Globes" about the unheard-of download speeds and greener networks coming soon.

Israel Innovation Authority Photo: PR Israel to double number of high-tech employees

The Israel Innovation Authority's annual report includes an operational plan for doubling the proportion of high-tech employees in the workforce over the next decade. 

Arie Belldegrun Photo: PR "Chemotherapy will become just a bad memory"

More energetic than ever, Arie Belldegrun talks to "Globes" about Kite Pharma's remarkable journey and the future of cancer treatment.

Binary options Photo: Shutterstock FBI targets Israeli binary options traders

The FBI recently managed to arrest the CEO of an Israeli based binary options company.

MARKET DATA
MOST POPULAR
BusinessWire
NEWS

MARKET

ECONOMY

POLITICS

TOURISM

LEGAL

TELECOM & MEDIA

RETAILING

DEFENSE & AEROSPACE

TRANSPORT & INFRASTRUCTURE

HEALTHCARE

EMPLOYMENT

ENERGY

INFORMATION TECHNOLOGY

STARTUPS

FINANCIAL SERVICES

REAL ESTATE

Twitter Facebook Linkedin RSS Newsletters גלובס MAD Conference 2017